OZEMPIC.BOT
v2.1 · GLP-1 INDEX
OZEMPIC $968.52 ↓ 2.1%·WEGOVY $1,349.02 ↑ 0.4%·MOUNJARO $1,069.08 ↓ 1.8%·ZEPBOUND $1,086.37 → 0.0%·FDA · SHORTAGE RESOLVED · OCT 2024·NOVO NORDISK Q3 REVENUE +29%·ELI LILLY MARKET CAP $720B·COMPOUNDED SEMAGLUTIDE BAN UPDATE·OZEMPIC $968.52 ↓ 2.1%·WEGOVY $1,349.02 ↑ 0.4%·MOUNJARO $1,069.08 ↓ 1.8%·ZEPBOUND $1,086.37 → 0.0%·FDA · SHORTAGE RESOLVED · OCT 2024·NOVO NORDISK Q3 REVENUE +29%·ELI LILLY MARKET CAP $720B·COMPOUNDED SEMAGLUTIDE BAN UPDATE·
§ 04

Insurance

Coverage rules vary widely. This is a snapshot of how the major U.S. plans handle each GLP-1.

Carrier · UnitedHealthcare

UnitedHealthcare

ozempic
Conditional

Covered (Tier 2) with PA for diabetes diagnosis. Step therapy may apply.

wegovy
Not covered

Not covered for weight loss only; PA required if obesity + comorbidity.

mounjaro
Conditional

Covered (Tier 2) with PA for T2D. Step therapy required.

zepbound
Not covered

Covered with PA on select employer plans. Not on standard formulary.

⌗ Data source — Coverage data from public payer formularies and CMS datasets. Always verify with your insurance provider.
Glossary

PA — Prior authorization required. Your prescriber must justify the prescription.

Step therapy — You must try cheaper alternatives first.

Tier 2/3 — Higher copay than generics; varies by employer plan design.